246 related articles for article (PubMed ID: 36858582)
21. Reprint of: revisiting oxidative stress and mitochondrial dysfunction in the pathogenesis of Parkinson disease-resemblance to the effect of amphetamine drugs of abuse.
Perfeito R; Cunha-Oliveira T; Rego AC
Free Radic Biol Med; 2013 Sep; 62():186-201. PubMed ID: 23743292
[TBL] [Abstract][Full Text] [Related]
22. Modeling Parkinson's disease using induced pluripotent stem cells.
Byers B; Lee HL; Reijo Pera R
Curr Neurol Neurosci Rep; 2012 Jun; 12(3):237-42. PubMed ID: 22538490
[TBL] [Abstract][Full Text] [Related]
23. Aldehyde dehydrogenase 1 defines and protects a nigrostriatal dopaminergic neuron subpopulation.
Liu G; Yu J; Ding J; Xie C; Sun L; Rudenko I; Zheng W; Sastry N; Luo J; Rudow G; Troncoso JC; Cai H
J Clin Invest; 2014 Jul; 124(7):3032-46. PubMed ID: 24865427
[TBL] [Abstract][Full Text] [Related]
24. Reduced complement of dopaminergic neurons in the substantia nigra pars compacta of mice with a constitutive "low footprint" genetic knockout of alpha-synuclein.
Goloborshcheva VV; Chaprov KD; Teterina EV; Ovchinnikov R; Buchman VL
Mol Brain; 2020 May; 13(1):75. PubMed ID: 32393371
[TBL] [Abstract][Full Text] [Related]
25. Alpha-Synuclein Gene Alterations Modulate Tyrosine Hydroxylase in Human iPSC-Derived Neurons in a Parkinson's Disease Animal Model.
Bernal-Conde LD; Peña-Martínez V; Morato-Torres CA; Ramos-Acevedo R; Arias-Carrión Ó; Padilla-Godínez FJ; Delgado-González A; Palomero-Rivero M; Collazo-Navarrete O; Soto-Rojas LO; Gómez-Chavarín M; Schüle B; Guerra-Crespo M
Life (Basel); 2024 Jun; 14(6):. PubMed ID: 38929711
[TBL] [Abstract][Full Text] [Related]
26. Demonstration of brain region-specific neuronal vulnerability in human iPSC-based model of familial Parkinson's disease.
Brazdis RM; Alecu JE; Marsch D; Dahms A; Simmnacher K; Lörentz S; Brendler A; Schneider Y; Marxreiter F; Roybon L; Winner B; Xiang W; Prots I
Hum Mol Genet; 2020 May; 29(7):1180-1191. PubMed ID: 32160287
[TBL] [Abstract][Full Text] [Related]
27. Physiological characterisation of human iPS-derived dopaminergic neurons.
Hartfield EM; Yamasaki-Mann M; Ribeiro Fernandes HJ; Vowles J; James WS; Cowley SA; Wade-Martins R
PLoS One; 2014; 9(2):e87388. PubMed ID: 24586273
[TBL] [Abstract][Full Text] [Related]
28. CRISPR-Cas9 Gene Editing Protects from the A53T-SNCA Overexpression-Induced Pathology of Parkinson's Disease
Yoon HH; Ye S; Lim S; Jo A; Lee H; Hong F; Lee SE; Oh SJ; Kim NR; Kim K; Kim BJ; Kim H; Lee CJ; Nam MH; Hur JW; Jeon SR
CRISPR J; 2022 Feb; 5(1):95-108. PubMed ID: 35191750
[TBL] [Abstract][Full Text] [Related]
29. Mutant α-Synuclein Overexpression Induces Stressless Pacemaking in Vagal Motoneurons at Risk in Parkinson's Disease.
Lasser-Katz E; Simchovitz A; Chiu WH; Oertel WH; Sharon R; Soreq H; Roeper J; Goldberg JA
J Neurosci; 2017 Jan; 37(1):47-57. PubMed ID: 28053029
[TBL] [Abstract][Full Text] [Related]
30. Grafts Derived from an α-Synuclein Triplication Patient Mediate Functional Recovery but Develop Disease-Associated Pathology in the 6-OHDA Model of Parkinson's Disease.
Shrigley S; Nilsson F; Mattsson B; Fiorenzano A; Mudannayake J; Bruzelius A; Ottosson DR; Björklund A; Hoban DB; Parmar M
J Parkinsons Dis; 2021; 11(2):515-528. PubMed ID: 33361611
[TBL] [Abstract][Full Text] [Related]
31. Nitration of microtubules blocks axonal mitochondrial transport in a human pluripotent stem cell model of Parkinson's disease.
Stykel MG; Humphries K; Kirby MP; Czaniecki C; Wang T; Ryan T; Bamm V; Ryan SD
FASEB J; 2018 Oct; 32(10):5350-5364. PubMed ID: 29688812
[TBL] [Abstract][Full Text] [Related]
32. α-Synuclein BAC transgenic mice exhibit RBD-like behaviour and hyposmia: a prodromal Parkinson's disease model.
Taguchi T; Ikuno M; Hondo M; Parajuli LK; Taguchi K; Ueda J; Sawamura M; Okuda S; Nakanishi E; Hara J; Uemura N; Hatanaka Y; Ayaki T; Matsuzawa S; Tanaka M; El-Agnaf OMA; Koike M; Yanagisawa M; Uemura MT; Yamakado H; Takahashi R
Brain; 2020 Jan; 143(1):249-265. PubMed ID: 31816026
[TBL] [Abstract][Full Text] [Related]
33. Opposing effects of β-2 and β-1 adrenergic receptor signaling on neuroinflammation and dopaminergic neuron survival in α-synuclein-mediated neurotoxicity.
Torrente D; Su EJ; Schielke GP; Warnock M; Mann K; Lawrence DA
J Neuroinflammation; 2023 Mar; 20(1):56. PubMed ID: 36864439
[TBL] [Abstract][Full Text] [Related]
34. Host-to-graft propagation of inoculated α-synuclein into transplanted human induced pluripotent stem cell-derived midbrain dopaminergic neurons.
Gima S; Oe K; Nishimura K; Ohgita T; Ito H; Kimura H; Saito H; Takata K
Regen Ther; 2024 Mar; 25():229-237. PubMed ID: 38283940
[TBL] [Abstract][Full Text] [Related]
35. Midbrain organoids with an
Mohamed NV; Sirois J; Ramamurthy J; Mathur M; Lépine P; Deneault E; Maussion G; Nicouleau M; Chen CX; Abdian N; Soubannier V; Cai E; Nami H; Thomas RA; Wen D; Tabatabaei M; Beitel LK; Singh Dolt K; Karamchandani J; Stratton JA; Kunath T; Fon EA; Durcan TM
Brain Commun; 2021; 3(4):fcab223. PubMed ID: 34632384
[No Abstract] [Full Text] [Related]
36. Nuclease-dead S.
Sastre D; Zafar F; Torres CAM; Piper D; Kirik D; Sanders LH; Qi S; Schüle B
bioRxiv; 2023 Jan; ():. PubMed ID: 36747875
[TBL] [Abstract][Full Text] [Related]
37. The Parkinson's disease variant rs356182 regulates neuronal differentiation independently from alpha-synuclein.
Prahl JD; Pierce SE; van der Schans EJC; Coetzee GA; Tyson T
Hum Mol Genet; 2023 Jan; 32(1):1-14. PubMed ID: 35866299
[TBL] [Abstract][Full Text] [Related]
38. Neuronal-type-specific epigenome editing to decrease
Sun Z; Kantor B; Chiba-Falek O
Mol Ther Nucleic Acids; 2024 Mar; 35(1):102084. PubMed ID: 38130373
[TBL] [Abstract][Full Text] [Related]
39. Lentiviral Vector Platform for the Efficient Delivery of Epigenome-editing Tools into Human Induced Pluripotent Stem Cell-derived Disease Models.
Tagliafierro L; Ilich E; Moncalvo M; Gu J; Sriskanda A; Grenier C; Murphy SK; Chiba-Falek O; Kantor B
J Vis Exp; 2019 Mar; (145):. PubMed ID: 30985756
[TBL] [Abstract][Full Text] [Related]
40. Axonal pathology in hPSC-based models of Parkinson's disease results from loss of Nrf2 transcriptional activity at the Map1b gene locus.
Czaniecki C; Ryan T; Stykel MG; Drolet J; Heide J; Hallam R; Wood S; Coackley C; Sherriff K; Bailey CDC; Ryan SD
Proc Natl Acad Sci U S A; 2019 Jul; 116(28):14280-14289. PubMed ID: 31235589
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
